Lynparza 100 mg film-coated tablets, AZD2281, AZD2281, AZD2281 clinical trials

A Phase I, Open-label, Parallel Group Study to Investigate Olaparib Safety and Tolerability, Efficacy and Pharmacokinetics in Paediatric Patients with Solid Tumours

This study is looking at a medicine called olaparib (also known as Lynparza) in children and young people with solid tumours. We want to see how safe it is, how well it's tolerated, and how the body handles it. This helps us find the right dose for future use.